Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital ...

(ORLANDO, Dec. 6, 2025) Taking the sickle cell drug hydroxyurea during or shortly before pregnancy does not appear to cause specific issues in newborns, according to the first prospective study of ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

Hydroxyurea was used in a 25-year-old man with SCD who had AP and recurrent SP. [21] The patient had received hydralazine, piracetam, and pentoxifylline, but the AP and SP episodes continued over the ...

Machine learning identified RDW and HGB as key predictors of hydroxyurea resistance in polycythemia vera, aiding early identification and treatment adjustment. The PV-AIM study used electronic health ...